美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

GSK plc ADRhedged

73.23

-0.2820-0.38%

成交量：234.00

成交额：1.71万

市值：73.24万

市盈率：- -

高：73.26

开：73.26

低：73.00

收：73.51

52周最高：85.03

52周最低：48.14

股本：1.00万

流通股本：1.00万

量比：0.82

换手率：2.34%

股息：1.15

股息率：1.57%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

蛇串疮百亿级市场的“冰与火”：GSK全球市场“独舞” 百克生物遭遇“极寒”

华夏时报网

股海导航_2026年3月19日_沪深股市公告与交易提示

4000万美元首付款到账：前沿生物与GSK授权合作协议持续推进中

GSK(GSK.US)乙肝新药在中国拟纳入优先审评有望实现乙肝功能性治愈

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/GSKH"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":73.2322,"timestamp":1774036800000,"preClose":73.5142,"halted":0,"volume":234,"delay":0,"changeRate":-0.0038359935903539244,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"休市中","change":-0.282,"latestTime":"03-20 16:00:00 EDT","open":73.26,"high":73.26,"low":73,"amount":17115.3577,"amplitude":0.003537,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":73.5142,"nav":73.86905,"aum":738764.36905,"dividendRate":0.01566,"bidAskSpread":0,"volumeRatio":0.8153314934019298},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8153314934019298,"shares":10001,"dividePrice":1.1468,"high":73.26,"amplitude":0.003537,"preClose":73.5142,"low":73,"week52Low":48.14,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":73.2322,"eps":0,"divideRate":0.01566,"volume":234,"delay":0,"ttmEps":0,"open":73.26,"prevYearClose":68.2031,"prevWeekClose":76.455,"prevMonthClose":82.5898,"prevQuarterClose":68.2031,"fiveDayClose":76.455,"twentyDayClose":83.2344,"sixtyDayClose":67.704},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621520765","title":"蛇串疮百亿级市场的“冰与火”：GSK全球市场“独舞” 百克生物遭遇“极寒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2621520765","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621520765?lang=zh_cn&edition=fundamental","pubTime":"2026-03-21 10:20","pubTimestamp":1774059600,"startTime":"0","endTime":"0","summary":"春寒料峭谨防“会呼吸的痛”。随着春季气温波动，病毒进入活跃期，流行病传染病高发。带状疱疹，这个民间俗称“蛇串疮”的疾病，正以极高发病率威胁着大众健康。2025年发布的《中国带状疱疹疾病负担与经济学评价研究》显示，带状疱疹新发病例呈现年轻化，全人群终身发病风险超过30%。而与庞大市场需求形成鲜明对比的是，国内疫苗接种率的持续低迷。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603213679560322.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603213679560322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4007","LU1829250122.USD","688276","BK4588","GSK.UK","GSK","BK4532","BK4585","BK0239","GSKH"],"gpt_icon":0},{"id":"2620950692","title":"股海导航_2026年3月19日_沪深股市公告与交易提示","url":"https://stock-news.laohu8.com/highlight/detail?id=2620950692","media":"股市直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620950692?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 07:16","pubTimestamp":1773875760,"startTime":"0","endTime":"0","summary":"　　基蛋生物公告称，公司股票于3月16日、17日、18日连续3个交易日收盘价格涨幅偏离值累计达20%，构成交易异常波动。公司目前拟筹划出售控股子公司上海绿馨电子科技有限公司60%的股权，相关交易可能对公司净利润造成小幅度影响，可能触发信息披露标准。　　众泰汽车公告称，公司全资子公司浙江深康汽车车身模具有限公司于3月18日复工复产，正式恢复生产经营。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-03-19/doc-inhrnkuc8857594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GSK.UK","BK4585","BK4588","GSK","BK4007","GSKH","BK4532","LU1829250122.USD"],"gpt_icon":0},{"id":"2620235848","title":"4000万美元首付款到账：前沿生物与GSK授权合作协议持续推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2620235848","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620235848?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 16:15","pubTimestamp":1773821756,"startTime":"0","endTime":"0","summary":"3月18日，前沿生物（688221）发布公告，截至本公告披露日，公司已收到由葛兰素史克（GSK.N）按协议约定支付的4000万美元首付款。据悉，2026年2月16日，公司与葛兰素史克签署独家授权许可协议，葛兰素史克将获得两款小核酸（siRNA）管线产品在全球范围内的独家开发、生产及商业化权利。2025年前三季度，前沿生物实现收入1.03亿元，归母净利润-1.60亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603183675959935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GSK.UK","BK4532","LU1829250122.USD","BK4588","688221","GSKH","BK4007","GSK","BK0239","BK4585"],"gpt_icon":0},{"id":"2620942079","title":"GSK(GSK.US)乙肝新药在中国拟纳入优先审评 有望实现乙肝功能性治愈","url":"https://stock-news.laohu8.com/highlight/detail?id=2620942079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620942079?lang=zh_cn&edition=fundamental","pubTime":"2026-03-17 21:33","pubTimestamp":1773754400,"startTime":"0","endTime":"0","summary":"此前该药已在国内获得突破性疗法资格，此次拟纳入优先审评，意味着这款全球首个有望实现乙肝功能性治愈的反义寡核苷酸类疗法距离中国患者又近一步。若获批，Bepirovirsen将成为全球首个仅需6个月有限疗程治疗便可实现乙肝功能性治愈的抗病毒疗法。GSK计划于2026年第一季度正式启动全球监管审批申请，该药已在日本申报上市。Bepirovirsen显示出具有统计学与临床意义的功能性治愈率。与单用标准治疗相比，bepirovirsen联合标准治疗显著提高了功能性治愈率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU1829250122.USD","GSK.UK","BK4585","GSK","BK4532","BK4007","GSKH"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GSKH\",params:#limit:6,delay:false,,,undefined,":[]}}